The progenitor P{EP}EP35-147 insertion is also still present on the chromosome.
Amino acid replacement: W124term.
G14067088A
W124term | foxo-PB; W124term | foxo-PC; W124term | foxo-PF; W124term | foxo-PG; W124term | foxo-PH
W124term
G to A nucleotide change at the second or third position of the Trp codon leads to a nonsense mutation. (exact site of mutation unspecified). Site of nucleotide substitution in mutant inferred by FlyBase based on reported amino acid change.
short lived (with foxo21)
The eyes of foxo25 mutant flies have a smaller average ommatidia area than controls and a higher ommatidia number.
Mutant embryos have a normal somatic muscle pattern. The size of the segmental border muscle and the DA1 muscle and also the number of nuclei present in these muscles are normal.
Adult brains have a significant decrease in dopaminergic neuron number (especially in the DL1 cluster) in 30 day old foxo21/foxo25 flies. Climbing ability in foxo21/foxo25 is significantly worse (at both 3 and even more so at 15 days old) and there is a significant reduction in ATP of the indirect flight muscle compared to wild type at 15 (but not 3) days old.
Mushroom body neuroblasts persist slightly longer than normal in mutant animals.
foxo21/foxo25 mutants rapidly become arrythmic in the presence of low levels of paraquat (0.5-1mM), while wild-type flies retain their rhythms for a few weeks. Phototaxis is not affected by paraquat treatment in these mutants.
foxo21/foxo25 mutant flies are hypersensitive to oxidative stress.
30 day old foxo21/foxo25 mutant flies show weak rhythms simliar to those seen in response to paraquat in young flies.
foxoBG01018/foxo25 flies display a 4.8% improvement in medial survival following M.marinum infection in comparison to wild-type flies - 174 hours vs. 166 hours. foxo21/foxo25 and foxo25/Df(3R)ED5634 transheterozygotes survive even longer - 190 hours following infection. The number of bacteria recorded in these flies is not significantly different from wild-type flies.
Salivary glands are destroyed at the same time in homozygous pupae as in wild-type pupae.
Shows no obvious phenotype under normal culturing conditions, though close inspection reveals the wing size is slightly reduced. Clonal analysis in the head capsule reveals no effect on growth. Clonal analysis reveals no difference of cell size in the developing eye between mutant and wild type. No significant difference between body weight of mutant and wild type flies is detectable. When placed on hydrogen-peroxide-containing food mutant flies display significantly reduced survival time compared to control flies. A similar effect occurs in response to paraquat feeding.
foxo25/foxo21 has decreased cell number | adult stage phenotype, non-enhanceable by Pink1B9
foxo25/foxo21 has abnormal stress response phenotype, suppressible by Scer\GAL4Act5C.PU/ThorUAS.cTa
foxo25 is an enhancer of visible | somatic clone phenotype of Tsc1Q87X
foxo25/foxo21 is an enhancer of decreased cell size phenotype of chicoflp147E/chico1
foxo25/foxo21 is a non-enhancer of abnormal locomotor behavior | adult stage phenotype of Pink1B9
foxo25/foxo21 is a non-enhancer of increased cell death | adult stage phenotype of Pink1B9
foxo25/foxo[+] is a non-enhancer of short lived phenotype of Crtc25-3
foxo25/foxo[+] is a non-enhancer of abnormal stress response phenotype of Crtc25-3
foxo25/foxo21 is a suppressor of abnormal oxidative stress response | adult stage | chemical conditional phenotype of Trap1EY21851
foxo25/foxo[+] is a suppressor of increased cell death | somatic clone phenotype of pieE1-16
foxo25/foxo[+] is a suppressor of increased cell death | larval stage phenotype of Hsap\APPAβ42.UAS.cUa, Scer\GAL4elav.PU
foxo25/foxo[+] is a suppressor of lethal phenotype of Hsap\APPAβ42.UAS.cUa, Scer\GAL4elav.PU
foxo25/foxo[+] is a suppressor of abnormal locomotor behavior phenotype of Hsap\APPAβ42.UAS.cUa, Scer\GAL4elav.PU
foxo25/foxo25 is a suppressor of visible phenotype of Scer\GAL4GMR.PU, Sirt1UAS.cGa
foxo25/foxo25 is a suppressor | partially of abnormal eye color phenotype of Scer\GAL4GMR.PU, Sirt1UAS.cGa
foxo25/foxo[+] is a suppressor | partially of decreased body size | adult stage phenotype of Scer\GAL4Ilp2.PR, hepAct.UAS
foxo25/foxo[+] is a suppressor of long lived | dominant phenotype of pucE69
foxo25 is a suppressor | partially of visible | somatic clone phenotype of InR304
foxo25/foxo21 is a suppressor of decreased cell number phenotype of chicoflp147E/chico1
foxo25/foxo21 is a suppressor of visible phenotype of chicoflp147E/chico1
foxo25/foxo21 is a suppressor | partially of decreased body size phenotype of chicoflp147E/chico1
foxo25 is a suppressor | partially of visible | somatic clone phenotype of Pi3K92E5W3
foxo25/foxo21 is a suppressor of lethal | larval stage phenotype of Akt1
foxo25 is a suppressor of visible | somatic clone phenotype of Akt1
foxo25 is a suppressor of visible | somatic clone phenotype of Pten117
foxo25, foxo21, Sirt1UAS.cGa, Scer\GAL4arm.PU is a non-suppressor of abnormal locomotor behavior | adult stage phenotype of Pink1B9
foxo25, foxo21, Sirt1UAS.cGa, Scer\GAL4arm.PU is a non-suppressor of increased cell death | adult stage phenotype of Pink1B9
foxo25/foxo[+] is a non-suppressor of short lived phenotype of Crtc25-3
foxo25/foxo[+] is a non-suppressor of abnormal stress response phenotype of Crtc25-3
foxo25/foxo[+] is a non-suppressor of decreased cell death phenotype of Pi3K92EUAS.Tag:MYC, Scer\GAL4hs.PB
foxo25/foxo25 is a non-suppressor of decreased cell death phenotype of Pi3K92EUAS.Tag:MYC, Scer\GAL4hs.PB
foxo25 has ommatidium phenotype, enhanceable by Akt52
foxo25 has ommatidium phenotype, enhanceable by Akt57
foxo25 has ommatidium phenotype, enhanceable by Akt04226
foxo25/foxo21 has dorso-lateral dopaminergic neuron phenotype, non-enhanceable by Pink1B9
foxo25 has ommatidium phenotype, non-suppressible by Akt04226
foxo25 has ommatidium phenotype, non-suppressible by Akt52
foxo25 has ommatidium phenotype, non-suppressible by Akt57
foxo25 is an enhancer of ommatidium phenotype of Akt52
foxo25 is an enhancer of ommatidium phenotype of Akt57
foxo25 is an enhancer of ommatidium phenotype of Akt04226
foxo25 is an enhancer of adult head capsule | somatic clone phenotype of Tsc1Q87X
foxo25/foxo21 is an enhancer of ommatidium phenotype of chicoflp147E/chico1
foxo25/foxo21 is a non-enhancer of adult thorax phenotype of Pink1B9
foxo25/foxo21 is a non-enhancer of mitochondrion | adult stage phenotype of Pink1B9
foxo25/foxo21 is a non-enhancer of indirect flight muscle cell phenotype of Pink1B9
foxo25/foxo21 is a non-enhancer of wing blade phenotype of Pink1B9
foxo25/foxo21 is a suppressor of escort cell phenotype of InRE19/InR339
foxo25 is a suppressor | partially of ommatidium phenotype of Akt04226
foxo25 is a suppressor | partially of ommatidium phenotype of Akt52
foxo25 is a suppressor | partially of ommatidium phenotype of Akt57
foxo25/foxo[+] is a suppressor of male germline stem cell | germline clone phenotype of pieE1-16
foxo25/foxo[+] is a suppressor of eye disc | somatic clone phenotype of pieE1-16
foxo25/foxo[+] is a suppressor of eye phenotype of Hsap\APPAβ42.GMR.Tag:SS(rPENK)
foxo25/foxo25 is a suppressor | partially of eye phenotype of Scer\GAL4GMR.PU, Sirt1UAS.cGa
foxo25 is a suppressor | partially of adult head capsule | somatic clone phenotype of InR304
foxo25/foxo21 is a suppressor of ommatidium phenotype of chicoflp147E/chico1
foxo25/foxo21 is a suppressor of wing phenotype of chicoflp147E/chico1
foxo25 is a suppressor | partially of adult head capsule | somatic clone phenotype of Pi3K92E5W3
foxo25 is a suppressor of adult head capsule | somatic clone phenotype of Akt1
foxo25 is a suppressor of adult head capsule | somatic clone phenotype of Pten117
foxo25, foxo21, Sirt1UAS.cGa, Scer\GAL4arm.PU is a non-suppressor of mitochondrion | adult stage phenotype of Pink1B9
foxo25, foxo21, Sirt1UAS.cGa, Scer\GAL4arm.PU is a non-suppressor of indirect flight muscle cell phenotype of Pink1B9
foxo25, foxo21, Sirt1UAS.cGa, Scer\GAL4arm.PU is a non-suppressor of wing blade phenotype of Pink1B9
foxo25, foxo21, Sirt1UAS.cGa, Scer\GAL4arm.PU is a non-suppressor of adult thorax phenotype of Pink1B9
foxo25/foxo21 is a non-suppressor of eye phenotype of CrtcUAS.cWa, Scer\GAL4GMR.PF
foxo25/foxo[+] is a non-suppressor of embryonic/larval salivary gland phenotype of Pi3K92EUAS.Tag:MYC, Scer\GAL4hs.PB
foxo25/foxo25 is a non-suppressor of embryonic/larval salivary gland phenotype of Pi3K92EUAS.Tag:MYC, Scer\GAL4hs.PB
Scer\GAL4wor.PA, foxo25, grimRNAi.RHG.UAS, hidRNAi.RHG.UAS, rprRNAi.RHG.UAS has adult mushroom body phenotype
Scer\GAL4wor.PA, foxo25, grimRNAi.RHG.UAS, hidRNAi.RHG.UAS, rprRNAi.RHG.UAS has neuroblast | ectopic phenotype
Akt1, foxo25 has embryonic/larval salivary gland phenotype
Presence of foxo25/foxo21 significantly suppresses increased survival in response to rotenone or paraquat in Trap1EY21851/Trap1EY21851 flies. Presence of foxo25/foxo21 suppresses rescue via feeding of G-TTP of locomotor defects in Pink1B9/Pink1B9 flies.
The reduction in ommatidium area seen in either mutant alone is enhanced in Akt104226 foxo25 double mutant flies. As in the foxo25 mutant alone, ommatidium number is increased.
The reduction in ommatidium area seen in either mutant alone is enhanced in Akt157 foxo25 double mutant flies. As in the foxo25 mutant alone, ommatidium number is increased.
The reduction in ommatidium area seen in either mutant alone is enhanced in Akt152 foxo25 double mutant flies. As in the foxo25 mutant alone, ommatidium number is increased.
Expression of Sirt1Scer\UAS.cGa driven by Scer\GAL4arm.PU partially suppresses phenotypes (collapsed thorax, downturned wings, swollen mitochondria along with increased cell death and reduced levels of mtDNA and ATP in the indirect flight muscle and locomotor defects) seen in (3 day old) Pink1B9/Y flies. Presence of foxo25/foxo21 almost completely nullifies the suppressive effect of Scer\GAL4arm.PU>Sirt1Scer\UAS.cGa on phenotypes in Pink1B9/Y flies.
foxo25/foxo21 does not significantly enhance phenotypes (collapsed thorax, downturned wings, swollen mitochondria along with increased cell death and reduced levels of mtDNA and ATP in the indirect flight muscle and locomotor defects) seen in Pink1B9/Y flies.
Pink1B9/Y does not enhance dopaminergic neuron loss (in the DL1 cluster) in foxo21/foxo25 flies.
Neuroblasts are detected in the mushroom body of 2 week old and even in 1 month old adults simultaneously co-expressing rprmiRNA.RHG.Scer\UAS, WmiRNA.RHG.Scer\UAS and grimmiRNA.RHG.Scer\UAS (from the P{UAS-RHG.miRNA} transgene) under the control of Scer\GAL4wor.PA in a foxo25 background (mushroom body neuroblasts are not seen in wild-type adults and are not seen at these late time points in adults expressing the P{UAS-RHG.miRNA} transgene under the control of Scer\GAL4wor.PA in a wild-type background or in foxo25 single mutant adults). Some of the 2 week old mutant mushroom body neuroblasts are large in size and generate many new progeny. There is a strong correlation between mushroom body neuroblast cell size and progeny number in 2 week old mutant adults, but not in younger mutant adults. In 1 month old mutant adults, some of the progeny of these neuroblasts show normal axon projections through the mushroom body pedunculus and some mistarget, bifurcating prematurely and projecting anterior to the pedunculus.
A significant recovery of eye pigmentation and structure is seen in flies expressing Sir2Scer\UAS.cGa under the control of Scer\GAL4GMR.PU in a foxo25/foxo25 background.
A foxo25 heterozygous background has no effect on survival or lipid accumulation in starved TORC25-3 homozygotes.
Removal of both copies of foxo (foxo25/foxo21) is lethal in TORC25-3 homozygotes.
TORCScer\UAS.cWa over-expressing flies (driven by Scer\GAL4GMR.PF) in which foxo is reduced or eliminated though a foxo25/foxo21 background still exhibit a rough eye phenotype.
foxo25 Akt11 double homozygotes show considerable lethality; most animals die before the pupal stage, with most of the remaining animals dying as pupae and only a few escapers eclosing as adults. 71% of pupae still contain intact salivary glands at 20 hours after puparium formation (this is approximately 6 hours after the glands are normally destroyed in wild-type animals).
Ectopic expression of ThorScer\UAS.cTa, under the control of Scer\GAL4Act5C can completely suppress the sensitivity of foxo21/foxo25 flies to oxidative stress (median life-span of 56.8 hours, 39.7% survival rate after 60 hours exposure to 5% hydrogen peroxide).
The increase in average and maximum lifespan seen in pucE69/+ adults is dominantly suppressed by foxo25. The reduction in body weight seen in 1 day old hepAct.Scer\UAS; Scer\GAL4Ilp2.PR adults is partially supressed by foxo25/+.
The ability of 0.5mM Psammaplysene A to suppress the eye degeneration phenotype caused by expression of Hsap\ARQ52.Scer\UAS under the control of Scer\GAL4GMR.PU (in the presence of dihydrotestosterone) is suppressed if the flies are also heterozygous for foxo25.
foxo25/foxo21 is rescued by foxoUAS.cFa/Scer\GAL4Lk6-DJ634
foxo25/foxo21 is rescued by foxoTag:V5
foxo25/foxo21 is not rescued by foxoUAS.cFa/Scer\GAL4P2.4.Pdf
foxo25/foxo21 is not rescued by foxoTag:V5
Expression of foxoT:SV5\V5 rescues the circadian arrhythmia seen in foxo21/foxo25 mutants. Phototaxis is not affected by paraquat treatment in these mutants.
Expression of foxoScer\UAS.cFa under the control of Scer\GAL4Lk6-DJ634 rescues the circadian arrhythmia seen in foxo21/foxo25 mutants. Phototaxis is not affected by paraquat treatment in these mutants.